Dermizole Vaginal Tablet Uses

What is the dose of your medication?
sponsored

What is Dermizole Vaginal Tablet?

Dermizole Vaginal Tablet lozenges are dissolved slowly in the mouth to prevent and treat thrush. Thrush, also called candidiasis or white mouth, is a fungus infection of the mouth and throat. Dermizole Vaginal Tablet may also be used for other problems as determined by your doctor.

Dermizole Vaginal Tablet is available only with your doctor's prescription.

Dermizole Vaginal Tablet indications

sponsored

Dermizole Vaginal Tablet Lozenges are indicated for the local treatment of oropharyngeal candidiasis. The diagnoses should be confirmed by a KOH smear and/or culture prior to treatment.

Dermizole Vaginal Tablet Lozenges are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. There are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence.

How should I use Dermizole Vaginal Tablet?

Use Dermizole Vaginal Tablet inserts as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Dermizole Vaginal Tablet inserts.

Uses of Dermizole Vaginal Tablet in details

sponsored

This product is a combination of B vitamins used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, alcoholism, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health. B vitamins include thiamine, riboflavin, niacin/niacinamide, vitamin B6, vitamin B12, folic acid, and pantothenic acid.

Some brands of B vitamins also contain ingredients such as vitamin C, vitamin E, biotin, or zinc. Consult your doctor or pharmacist if you have questions about the ingredients in your brand.

How to use Bco

Take this medication by mouth, usually once daily or as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

If you are taking a brand that contains vitamin C, take this medication by mouth with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise.

If you are taking chewable tablets, chew the tablet thoroughly before swallowing.

If you are taking extended-release capsules, swallow them whole. Do not crush or chew extended-release capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

If you are taking a liquid product, use a medication-measuring device to carefully measure the dose. Do not use a household spoon. Some liquid products need to be shaken before each dose. Some products that contain vitamin B12 need to be placed under the tongue and held there before swallowing. Follow label directions carefully to get the most benefit.

Take this medication regularly in order to get the most benefit from it. To help you remember, take it at the same time each day.

Dermizole Vaginal Tablet description

sponsored

Dermizole Vaginal Tablet is used as a topical ointment or cream in the treatment of Tinea infections. Tinea infections are superficial fungal infections caused by three species of fungi collectively known as dermatophytes (Trichophyton, Microsporum and Epidermophyton). Commonly these infections are named for the body part affected, including tinea corporis (general skin), tinea cruris (groin), and tinea pedis (feet). Dermizole Vaginal Tablet is a halogenated phenolic ether administered topically for dermotaphytic infections. The mechanism of action is unknown, but also presumed to interfere with yeast membrane structure and function.

Dermizole Vaginal Tablet dosage

Usual Adult Dose for Tinea Corporis

Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 weeks, depending on the nature and severity of the infection.

Usual Adult Dose for Tinea Cruris

Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 weeks, depending on the nature and severity of the infection.

Usual Adult Dose for Tinea Pedis

Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 to 8 weeks, depending on the nature and severity of the infection.

Usual Adult Dose for Cutaneous Candidiasis

Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.

Usual Adult Dose for Tinea Versicolor

Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.

Usual Adult Dose for Vaginal Candidiasis

Regimen 1: 100 mg (one 100 mg vaginal suppository) intravaginally once a day for 7 consecutive days alone or in combination with topical application of 1% Dermizole Vaginal Tablet cream to affected area two times daily for 7 consecutive days.

Regimen 2: 200 mg (one 200 mg vaginal suppository) intravaginally once a day for 3 consecutive days alone or in combination with topical application of 1% Dermizole Vaginal Tablet cream to affected area two times daily for 7 consecutive days.

Regimen 3: 500 mg (one 500 mg vaginal suppository) intravaginally once.

Regimen 4: One applicatorful of 1% Dermizole Vaginal Tablet vaginal cream intravaginally once daily (preferably at bedtime) for 7 consecutive days.

Regimen 5: One applicatorful of 2% Dermizole Vaginal Tablet vaginal cream intravaginally once daily (preferably at bedtime) for 3 consecutive days.

Studies have shown the three and seven day courses of Dermizole Vaginal Tablet to be equally effective. Patient compliance may be increased with a three day course. Patients who fail to achieve a cure with a single 500 mg dose should be treated with a 3 or 7 day course of Dermizole Vaginal Tablet.

Weekly or monthly Dermizole Vaginal Tablet vaginal suppositories appear to be effective topical regimens for chronic suppressive therapy in female patients with HIV.

Usual Pediatric Dose for Tinea Corporis

> 3 years: Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 weeks, depending on the nature and severity of the infection.

Usual Pediatric Dose for Tinea Cruris

> 3 years: Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 weeks, depending on the nature and severity of the infection.

Usual Pediatric Dose for Tinea Pedis

> 3 years: Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 to 8 weeks, depending on the nature and severity of the infection.

Usual Pediatric Dose for Cutaneous Candidiasis

> 3 years: Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.

Usual Pediatric Dose for Tinea Versicolor

> 3 years: Apply Dermizole Vaginal Tablet topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.

Usual Pediatric Dose for Vaginal Candidiasis

> 12 years: Regimen 1: 100 mg (one 100 mg vaginal suppository) intravaginally once a day for 7 consecutive days alone or in combination with topical application of 1% Dermizole Vaginal Tablet cream to affected area two times daily for 7 consecutive days.

Regimen 2: 200 mg (one 200 mg vaginal suppository) intravaginally once a day for 3 consecutive days alone or in combination with topical application of 1% Dermizole Vaginal Tablet cream to affected area two times daily for 7 consecutive days.

Regimen 3: 500 mg (one 500 mg vaginal suppository) intravaginally once.

Regimen 4: One applicatorful of 1% Dermizole Vaginal Tablet vaginal cream intravaginally once daily (preferably at bedtime) for 7 consecutive days.

Studies have shown the three and seven day courses of Dermizole Vaginal Tablet to be equally effective. Patient compliance may be increased with a three day course. Patients who fail to achieve a cure with a single 500 mg dose should be treated with a 3 or 7 day course of Dermizole Vaginal Tablet.

Weekly or monthly Dermizole Vaginal Tablet vaginal suppositories appear to be effective topical regimens for chronic suppressive therapy in female patients with HIV.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Dermizole Vaginal Tablet interactions

See also:
What other drugs will affect Dermizole Vaginal Tablet?

sponsored

Dermizole Vaginal Tablet should be used cautiously in patients with hyperthyroidism, hypertension and cardiac arrhythmias. All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.

Dermizole Vaginal Tablet should not be administered concomitantly with other sympathomimetic drugs (such as isoproterenol) because of possible additive effects and increased toxicity.

Combined effects may induce serious cardiac arrhythmias. They may be administered alternately when the preceding effect of other such drug has subsided.

Administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium, may induce cardiac arrhythmia.. When encountered, such arrhythmias may respond to administration of a beta-adrenergic blocking drug. Dermizole Vaginal Tablet also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.

Diuretic agents may decrease vascular response to pressor drugs such as epinephrine.

Dermizole Vaginal Tablet may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter.

Dermizole Vaginal Tablet side effects

See also:
What are the possible side effects of Dermizole Vaginal Tablet?

Applies to Dermizole Vaginal Tablet: lozenge/troche

In addition to its needed effects, some unwanted effects may be caused by Dermizole Vaginal Tablet (the active ingredient contained in Dermizole Vaginal Tablet Troche). In the event that any of these side effects do occur, they may require medical attention.

Minor Side Effects

Some of the side effects that can occur with Dermizole Vaginal Tablet may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common:

Note: Some of the side effects, such as abdominal or stomach cramping or pain or diarrhea, usually occur only when the medicine is swallowed

Dermizole Vaginal Tablet contraindications

See also:
What is the most important information I should know about Dermizole Vaginal Tablet?

Possible sensitivity to Dermizole Vaginal Tablet.

Rosacea, acne, perioral dermatitis, tuberculosis of the skin and varicose ulcers.

Dermizole Vaginal Tablet is not indicated for ophthalmic use and should be used with caution around the eyes.

Teratogenicity: Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are absorbed percutaneously, teratogenicity following topical application cannot be excluded.

Use in pregnancy: Dermizole Vaginal Tablet should not be used during pregnancy.

Active ingredient matches for Dermizole Vaginal Tablet:

Clotrimazole in Thailand.


Unit description / dosage (Manufacturer)Price, USD
Dermizole Vaginal Tablet 500 mg x 1's
Dermizole Vaginal Tablet vag tab 500 mg 1's (Community Pharm PCL)

List of Dermizole Vaginal Tablet substitutes (brand and generic names):

Dermizole 2% Cream (Community Pharm PCL)$ 0.22
Dermo Four Skin 10 gm Ointment (Teblik Drugs Ltd.)$ 0.34
Drep Clotrimazole 1 % w/v, Beclometasone dipropionate0.025 % w/v, Lidocainehydrochloride 2 % w/v, Ofloxacin 0.3 % w/v. EAR-DPS / 5ml (DWD Pharmaceuticals Ltd.)$ 0.42
5ml (DWD Pharmaceuticals Ltd.)$ 0.42
Drep Ear 5 ml Drop (DWD Pharmaceuticals Ltd.)$ 0.42
DREP EAR DROP 1 packet / 5 ML ear drop each (DWD Pharmaceuticals Ltd.)$ 0.56
DREP ear drops 5ml (DWD Pharmaceuticals Ltd.)$ 0.42
Drep Ear Drop (DWD Pharmaceuticals Ltd.)$ 0.67
DUDERM POWDER topical powd 1 % w/w x 75g (Zenon)
Cream; Topical; Clotrimazole (Merck dura)
Dydrozole Skin 15 gm Cream (Stiefel India (Pvt) Ltd)$ 0.89
Cream; Vaginal; Clotrimazole
Spray; Vaginal; Clotrimazole
170ml (Elfin)$ 0.54
Elcid Magaldrate 400 mg, simethicone20 mg. SYR / 170ml (Elfin)$ 0.54
ELCID SUSPENSION 1 bottle / 170 ML suspension each (Elfin)$ 0.69
ELCID syr 170ml (Elfin)$ 0.54
Elcid Suspension (Elfin)$ 0.69
Eligao Chloramphenicol 5 %, Lignocaine 2 %, Clotrimazole 1%, Beclometasone 0.025 %. EAR-DPS / 5ml (Forgo)$ 0.48
5ml (Forgo)$ 0.48
Eligao Chloramphenicol 5 %, Lignocaine 2 %, clotrimazole 1%, Beclometasone 0.025 %. EAR-DPS / 5ml (Forgo)$ 0.48
ELIGAO ear drops 5ml (Forgo)$ 0.48
Cream; Topical; Clotrimazole 1% (Bayer)
Cream; Topical; Clotrimazole 1%
Cream; Vaginal; Clotrimazole 1%
Tablet; Vaginal; Clotrimazole 500 mg
Tablets; Vaginal; Clotrimazole 500 mg
Capsule; Vaginal; Clotrimazole 200 mg
Capsules; Vaginal; Clotrimazole 200 mg
Capsule; Vaginal; Clotrimazole 100 mg
Capsules; Vaginal; Clotrimazole 100 mg

References

  1. DailyMed. "BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "clotrimazole". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "clotrimazole". http://www.drugbank.ca/drugs/DB00257 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Dermizole Vaginal Tablet are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Dermizole Vaginal Tablet. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


1 consumer reported age

Users%
16-291
100.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved